受强制性开放获取政策约束的文章 - Oleksandr Sverdlov了解详情
无法在其他位置公开访问的文章：2 篇
Adaptive randomization for clinical trials
WF Rosenberger, O Sverdlov, F Hu
Journal of biopharmaceutical statistics 22 (4), 719-736, 2012
强制性开放获取政策： US National Institutes of Health
Citalopram for acute and preventive efficacy in bipolar depression (CAPE-BD): a randomized, double-blind, placebo-controlled trial
SN Ghaemi, EA Whitham, PA Vohringer, SA Barroilhet, A Amerio, ...
The Journal of Clinical Psychiatry 82 (1), 6067, 2021
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：4 篇
On optimal designs for clinical trials: an updated review
O Sverdlov, Y Ryeznik, WK Wong
Journal of Statistical Theory and Practice 14 (1), 10, 2020
强制性开放获取政策： US National Institutes of Health
Pharmacometrics meets statistics—A synergy for modern drug development
Y Ryeznik, O Sverdlov, EM Svensson, G Montepiedra, AC Hooker, ...
CPT: Pharmacometrics & Systems Pharmacology 10 (10), 1134-1149, 2021
强制性开放获取政策： US National Institutes of Health
RARtool: A MATLAB software package for designing response-adaptive randomized clinical trials with time-to-event outcomes
Y Ryeznik, O Sverdlov, WK Wong
Journal of Statistical Software 66 (1), 2015
强制性开放获取政策： US National Institutes of Health
Sample size determination for the association between longitudinal and time‐to‐event outcomes using the joint modeling time‐dependent slopes parameterization
J LeClair, J Massaro, O Sverdlov, L Gordon, Y Tripodis
Statistics in medicine 41 (30), 5810-5829, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定